Nebivolol: third-generation beta-blockade - Wikidata - awgldk - TriplyDB

Nebivolol: third-generation beta-blockade

Nebivolol: third-generation beta-blockade

http://www.wikidata.org/entity/Q28238369

about

Clinical and economic aspects of the use of nebivolol in the treatment of elderly patients with heart failure Enantiomeric resolution of multiple chiral centres racemates by capillary electrophoresis.The Beta-1-Receptor Blocker Nebivolol Elicits Dilation of Cerebral Arteries by Reducing Smooth Muscle [Ca2+]i Chronic Nebivolol Treatment Suppresses Endothelin-1-Mediated Vasoconstrictor Tone in Adults With Elevated Blood Pressure.Pulmonary effects of nebivolol.Nebivolol in chronic heart failure: current evidence and future perspectives.Formulation and in vitro evaluation of bilayer tablets of nebivolol hydrochloride and nateglinide for the treatment of diabetes and hypertension Pharmacokinetics of nebivolol in the rat: low oral absorption, loss in the gut and systemic stereoselectivity.Enantioselective copper-catalyzed intramolecular phenolic O-H bond insertion: synthesis of chiral 2-carboxy dihydrobenzofurans, dihydrobenzopyrans, and tetrahydrobenzooxepines.Chiral resolution of multichiral center racemates by different modalities of chromatography

P2860

Q34386568-7459B88C-AB26-4FD2-94F0-1C91D4A99099 Q35912976-32F4F3C6-8BAD-4065-848A-D309F852311B Q36157478-F425A9DC-56D6-4325-A1D7-2CD8CB92C39A Q36912685-1298B4AD-2FFB-4E85-9B43-5DB126C22132 Q37564736-B4E212ED-6FDA-4A2E-867C-66FBCB187546 Q37716016-973485B3-2112-44E1-A565-9B715D8492E0 Q42150154-A8FAABC7-76B6-4200-9139-E5D2837BBA5E Q43857564-2C356DE3-F40E-432B-A9D2-A0483AD62BF0 Q45799347-88F7C7F8-D5CD-439A-97C2-28015215E271 Q59150021-5431DC12-2D4E-4E6D-8A24-8553841FD70B

P2860

Nebivolol: third-generation beta-blockade

http://www.wikidata.org/entity/Q28238369

description

2007 nî lūn-bûn

@nan

2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Nebivolol: third-generation beta-blockade

@ast

Nebivolol: third-generation beta-blockade

@en

Nebivolol: third-generation beta-blockade

@nl

type

label

Nebivolol: third-generation beta-blockade

@ast

Nebivolol: third-generation beta-blockade

@en

Nebivolol: third-generation beta-blockade

@nl

prefLabel

Nebivolol: third-generation beta-blockade

@ast

Nebivolol: third-generation beta-blockade

@en

Nebivolol: third-generation beta-blockade

@nl

P1433

Q28238369-9BA0BCA2-A055-4F1C-8219-8335D1B0F04F

P1476

Q28238369-061F099A-D6F1-4104-936A-88501E443650

P2093

Q28238369-1312D407-E5BD-4E07-936B-1E02C348C633

Q28238369-7D4C31F4-65F5-475D-92C1-F6E7B7101EDE

P2860

Q28238369-04765BD6-379D-4944-9784-6655F79D59CA

Q28238369-08FF0D79-4925-46B6-B52D-D662C0C6BDB3

Q28238369-091EB11A-69D3-41BA-A5A6-3C8BAB2E0F7D

Q28238369-0B7B0F5F-DCD2-42AC-B17C-D6C72C0BFEA9

Q28238369-0F60CDD6-10FD-4E80-9737-87266465A75B

Q28238369-159EC6B0-2ABB-4A26-AE74-D3F131BED785

Q28238369-19698C19-CCD5-4B53-A3D6-983CB861559A

Q28238369-202CDDDF-3412-4E78-8BD9-CFA74F393974

Q28238369-30B56350-5F8A-4741-8582-471D8BF03C84

Q28238369-3267A8E4-F28E-44D8-81E2-653564BF892E

P304

Q28238369-336AC449-F84B-49F4-A686-4118219CC084

P31

Q28238369-2BA40462-2EAE-4B02-B999-5D04BB97AE57

P3181

Q28238369-1903C000-1942-434D-8CD0-2328C8A87140

P356

Q28238369-A782A031-5B1B-4161-A3BC-843221A72ADA

P407

Q28238369-CF9A7618-5113-4EC7-949E-AF5E16EA2FDB

P433

Q28238369-B648159B-03FA-4A23-847B-DBD4EC63237B

P478

Q28238369-A3C72CB2-2EF2-47B7-8BDF-D325625382D2

P50

Q28238369-9EB618EB-A73A-4E1D-AD72-57A42044C460

P577

Q28238369-ED185F66-07E2-4169-8088-DFED09A6109D

P5875

Q28238369-0030DA23-DE97-4E51-8383-90A330C1478B

P698

Q28238369-243DF6E7-3742-453D-A4FF-EFF80E59CF07

P921

Q28238369-AEDDF4C6-1F8D-46E5-A89C-DCFB23934C0E

P3181

P356

14656566.8.10.1539

P1433

Expert Opinion on Pharmacotherapy

P1476

Nebivolol: third-generation beta-blockade

@en

P2093

Adriaan A Voors

http://www.w3.org/2001/XMLSchema#string

Rudolf A de Boer

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of effects on systolic and diastolic left ventricular function of nebivolol versus atenolol in patients with uncomplicated essential hypertension

Effects of nebivolol and atenolol on insulin sensitivity and haemodynamics in hypertensive patients

The role of the new beta-blockers in treating cardiovascular disease

Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy.

Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis.

Nebivolol in the management of essential hypertension: a review.

beta-adrenergic receptor blockade in chronic heart failure.

Nitric oxide mediated venodilator effects of nebivolol.

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

The influence of CYP2D6 phenotype on the clinical response of nebivolol in patients with essential hypertension

P304

1539-50

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3093381

http://www.w3.org/2001/XMLSchema#string

P356

10.1517/14656566.8.10.1539

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Dirk J van Veldhuisen

P577

2007-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6176878

http://www.w3.org/2001/XMLSchema#string

P698

17661735

http://www.w3.org/2001/XMLSchema#string

P921

rel-(αR,α′R,2R,2′S)-nebivolol